— Know what they know.
Not Investment Advice
Also trades as: NVV1.F (FSX) · $vol 0M

NVAX NASDAQ

Novavax, Inc.
1W: -12.3% 1M: -7.2% 3M: +36.5% YTD: +40.5% 1Y: +17.6% 3Y: +55.8% 5Y: -93.8%
$10.02
+0.62 (+6.60%)
 
Weekly Expected Move ±16.8%
$6 $8 $10 $11 $13
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 33 · $1.7B mcap · 146M float · 3.80% daily turnover · Short 51% of daily vol
Credit Risk of going bust: higher than 67% of companies Debt: 16.0% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.23 (down 98%), Novavax, Inc. would be worth roughly what it owes.
Total debt $295.6M against a stock market value of $1.55B.
Distance to default 3.65 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $144.9M (short-term plus half of long-term), stock volatility 68.7%; Altman Z'' -14.52. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Balance Sheet Trends

Total Assets
$1.2B -24.6% ▼
5Y CAGR: -5.8%
Total Liabilities
$1.3B -40.3% ▼
5Y CAGR: +6.4%
Shareholders Equity
-$128M +79.5% ▲
Cash & Investments
$735M -20.4% ▼
5Y CAGR: +0.7%
Total Debt
$249M +8.0% ▲
5Y CAGR: -11.9%
Net Debt
$8M +102.7% ▲

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$1.5B$1.3B$569M$530M$241M
Short-Term Investments$0$0$0$393M$494M
Cash & ST Investments$1.5B$1.3B$569M$923M$735M
Net Receivables$455M$82M$297M$108M$106M
Inventory$0$37M$42M$9M$12M
Other Current Assets$56M$87M$166M$33M$125M
Total Current Assets$2.2B$1.7B$1.1B$1.1B$978M
Property, Plant & Equip.$229M$400M$491M$300M$68M
Goodwill & Intangibles$136M$126M$127M$107M$113M
Long-Term Investments$2M$2M$0$0$0
Other Non-Current Assets$57M$28M$35M$24M$17M
Total Non-Current Assets$422M$555M$654M$431M$198M
Total Assets$2.6B$2.3B$1.8B$1.6B$1.2B
— Liabilities —
Accounts Payable$127M$217M$133M$42M$25M
Short-Term Debt$0$325M$0$0$3M
Deferred Revenue$1.4B$370M$241M$675M$140M
Other Current Liabilities$74M$983M$917M$280M$293M
Total Current Liabilities$2.4B$2.5B$1.6B$1.2B$460M
Long-Term Debt$323M$166M$168M$170M$246M
Other Non-Current Liab.$42M$56M$33M$360M$598M
Total Non-Current Liabilities$538M$433M$879M$1.0B$844M
Total Liabilities$2.9B$2.9B$2.5B$2.2B$1.3B
— Equity —
Common Stock$764K$868K$1M$2M$2M
Retained Earnings-$3.6B-$4.3B-$4.8B-$5.0B-$4.6B
Accumulated OCI-$1M-$6M$3M-$23M$2M
Total Stockholders Equity-$352M-$634M-$717M-$624M-$128M
Total Liabilities & Equity$2.6B$2.3B$1.8B$1.6B$1.2B
— Key Metrics —
Total Debt$454M$550M$229M$230M$249M
Net Debt-$1.1B-$787M-$339M-$300M$8M
Total Investments$2M$2M$0$393M$494M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms